Correlation Between Pfizer and Deutsche Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Deutsche Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Deutsche Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Deutsche Equity 500, you can compare the effects of market volatilities on Pfizer and Deutsche Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Deutsche Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Deutsche Equity.

Diversification Opportunities for Pfizer and Deutsche Equity

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Deutsche is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Deutsche Equity 500 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Deutsche Equity 500 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Deutsche Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Deutsche Equity 500 has no effect on the direction of Pfizer i.e., Pfizer and Deutsche Equity go up and down completely randomly.

Pair Corralation between Pfizer and Deutsche Equity

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Deutsche Equity. In addition to that, Pfizer is 2.3 times more volatile than Deutsche Equity 500. It trades about -0.11 of its total potential returns per unit of risk. Deutsche Equity 500 is currently generating about 0.37 per unit of volatility. If you would invest  17,920  in Deutsche Equity 500 on September 3, 2024 and sell it today you would earn a total of  1,024  from holding Deutsche Equity 500 or generate 5.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Deutsche Equity 500

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Deutsche Equity 500 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Deutsche Equity 500 are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Deutsche Equity may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pfizer and Deutsche Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Deutsche Equity

The main advantage of trading using opposite Pfizer and Deutsche Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Deutsche Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deutsche Equity will offset losses from the drop in Deutsche Equity's long position.
The idea behind Pfizer Inc and Deutsche Equity 500 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets